Dr/Ahmed Nabil
Who We Are
At Juphera, we are reimagining the future of generic drug registration. Our AI-powered platform is designed to help both pharmaceutical companies and drug regulatory authorities accelerate the Common Technical Dossier (CTD) review process—reducing timelines from over one year to just 10 days without compromising quality.
Founders
Juphera was founded by Ahmed Nabil, a pharmaceutical R&D leader with more than 20 years of experience in formulation development, regulatory submissions, and technology transfer across the MENA pharmaceutical market. His vision was clear: to use AI to eliminate the bottlenecks in drug approval, saving time, cost, and—most importantly—getting medicines to patients faster.
He is supported by a growing team of AI developers, regulatory experts, and industry partners, all driven by the same mission: accelerating trust in generics.
👤 Connect with Ahmed on LinkedIn
